Wealth Enhancement Advisory Services
APYX icon

Wealth Enhancement Advisory Services’s Apyx Medical APYX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-90,750
Closed -$124K – 3386
2025
Q1 		$124K Sell
90,750
-48
-0.1% -$66 ﹤0.01% 2723
2024
Q4 		$143K Hold
90,798
– – ﹤0.01% 2748
2024
Q3 		$113K Sell
90,798
-67,148
-43% -$84.8K ﹤0.01% 2538
2024
Q2 		$212K Sell
157,946
-99
-0.1% -$146 ﹤0.01% 2257
2024
Q1 		$215K Buy
158,045
+147
+0.1% +$313 ﹤0.01% 2143
2023
Q4 		$414K Sell
157,898
-386
-0.2% -$935 ﹤0.01% 1628
2023
Q3 		$507K Buy
+158,284
New +$738K ﹤0.01% 1416

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return